Sherlock gets $7.5M to create COVID-19 diagnostics

2020 02 20 18 12 3118 Money Bills 400

Open Philanthropy has advanced $7.5 million in grant funding to engineering biology company Sherlock Biosciences for diagnostics related to the novel coronavirus.

The nondilutive grant funding will help Sherlock further advance its CRISPR gene-editing technology platform, which it used to create its Sherlock CRISPR SARS-CoV-2 detection kit. The funding will also support the development of the company's Inspectr platform, which powers its COVID-19 diagnostic.

Sherlock is currently looking to hire 10 to 15 molecular diagnostic experts to help advance its Inspectr-based COVID-19 solution. The Inspectr platform aims to conduct instrument-free, handheld diagnostic tests that work similarly to an at-home pregnancy test.

Page 1 of 3
Next Page